ARTICLE | Company News
Alza receives EU approval recommendation
June 30, 2000 7:00 AM UTC
AZA partner Schering-Plough (SGP) said the European CPMP recommended approval of AZA's Caelyx pegylated liposomal doxorubicin to treat advanced ovarian cancer in women who have failed first-line plati...